These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3110 related articles for article (PubMed ID: 19464906)

  • 1. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.
    Cerfolio RJ; Ojha B; Bryant AS; Raghuveer V; Mountz JM; Bartolucci AA
    Ann Thorac Surg; 2004 Sep; 78(3):1017-23; discussion 1017-23. PubMed ID: 15337041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers.
    Liu BJ; Dong JC; Xu CQ; Zuo CT; Le JJ; Guan YH; Zhao J; Wu JF; Duan XH; Cao YX
    Chin Med J (Engl); 2009 Aug; 122(15):1749-54. PubMed ID: 19781319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA.
    Annema JT; Hoekstra OS; Smit EF; Veseliç M; Versteegh MI; Rabe KF
    Lung Cancer; 2004 Apr; 44(1):53-60. PubMed ID: 15013583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
    Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W
    Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer.
    Xu N; Wang M; Zhu Z; Zhang Y; Jiao Y; Fang W
    Chin Med J (Engl); 2014; 127(4):607-13. PubMed ID: 24534208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.
    Graafland NM; Leijte JA; Valdés Olmos RA; Hoefnagel CA; Teertstra HJ; Horenblas S
    Eur Urol; 2009 Aug; 56(2):339-45. PubMed ID: 19477581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
    Lardinois D; Weder W; Hany TF; Kamel EM; Korom S; Seifert B; von Schulthess GK; Steinert HC
    N Engl J Med; 2003 Jun; 348(25):2500-7. PubMed ID: 12815135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients.
    Ebihara A; Nomori H; Watanabe K; Ohtsuka T; Naruke T; Uno K; Kuwahira I; Eguchi K
    Jpn J Clin Oncol; 2006 Nov; 36(11):694-8. PubMed ID: 17068084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer.
    De Leyn P; Lardinois D; Van Schil PE; Rami-Porta R; Passlick B; Zielinski M; Waller DA; Lerut T; Weder W
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):1-8. PubMed ID: 17448671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
    Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
    Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients.
    Ohno Y; Koyama H; Nogami M; Takenaka D; Yoshikawa T; Yoshimura M; Ohbayashi C; Sugimura K
    J Magn Reson Imaging; 2007 Oct; 26(4):1071-80. PubMed ID: 17896365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
    Sivrikoz CM; Ak I; Simsek FS; Döner E; Dündar E
    Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of integrated positron emission tomography/computed tomography and mediastinoscopy in mediastinal staging of non-small cell lung cancer: analysis of 212 patients.
    Iskender I; Kapicibasi HO; Kadioglu SZ; Sevilgen G; Tezel C; Kosar' A; Atasalihi A; Kir A
    Acta Chir Belg; 2012; 112(3):219-25. PubMed ID: 22808763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer.
    von Haag DW; Follette DM; Roberts PF; Shelton D; Segel LD; Taylor TM
    J Surg Res; 2002 Apr; 103(2):160-4. PubMed ID: 11922730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transbronchial needle aspiration accurately diagnoses subcentimetre mediastinal and hilar lymph nodes detected by integrated positron emission tomography and computed tomography.
    Hsu LH; Ko JS; You DL; Liu CC; Chu NM
    Respirology; 2007 Nov; 12(6):848-55. PubMed ID: 17986113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria?
    Casiraghi M; Travaini LL; Maisonneuve P; Tessitore A; Brambilla D; Agoglia BG; Guarize J; Spaggiari L
    Eur J Cardiothorac Surg; 2011 Apr; 39(4):e38-43. PubMed ID: 21242094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 156.